- Home
- MBI vs TNGX Comparison
MBI vs TNGX Comparison
Compare MBI & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBI
- TNGX
- Stock Information
- Founded
- MBI 1973
- TNGX 2014
- Country
- MBI United States
- TNGX United States
- Employees
- MBI N/A
- TNGX N/A
- Industry
- MBI Property-Casualty Insurers
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- MBI Finance
- TNGX Health Care
- Exchange
- MBI Nasdaq
- TNGX Nasdaq
- Market Cap
- MBI 278.8M
- TNGX 317.4M
- IPO Year
- MBI 1987
- TNGX N/A
- Fundamental
- Price
- MBI $5.58
- TNGX $1.80
- Analyst Decision
- MBI Buy
- TNGX Strong Buy
- Analyst Count
- MBI 2
- TNGX 7
- Target Price
- MBI $6.75
- TNGX $12.33
- AVG Volume (30 Days)
- MBI 450.4K
- TNGX 801.9K
- Earning Date
- MBI 05-08-2025
- TNGX 05-07-2025
- Dividend Yield
- MBI N/A
- TNGX N/A
- EPS Growth
- MBI N/A
- TNGX N/A
- EPS
- MBI N/A
- TNGX N/A
- Revenue
- MBI $27,000,000.00
- TNGX $42,069,000.00
- Revenue This Year
- MBI N/A
- TNGX N/A
- Revenue Next Year
- MBI N/A
- TNGX N/A
- P/E Ratio
- MBI N/A
- TNGX N/A
- Revenue Growth
- MBI 285.71
- TNGX 15.17
- 52 Week Low
- MBI $3.22
- TNGX $1.71
- 52 Week High
- MBI $7.46
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- MBI 42.19
- TNGX 31.59
- Support Level
- MBI $4.93
- TNGX $1.80
- Resistance Level
- MBI $5.69
- TNGX $2.04
- Average True Range (ATR)
- MBI 0.32
- TNGX 0.21
- MACD
- MBI 0.02
- TNGX 0.01
- Stochastic Oscillator
- MBI 55.60
- TNGX 3.94
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.